SE396011B - Forfarande for framstellning av en i huvudsak klar, steril vattenlosning av 1,3-bis(2-karboxikromon-5-yloxi)-propan-2-ol eller ett farmaceutiskt godtagbart salt derav - Google Patents

Forfarande for framstellning av en i huvudsak klar, steril vattenlosning av 1,3-bis(2-karboxikromon-5-yloxi)-propan-2-ol eller ett farmaceutiskt godtagbart salt derav

Info

Publication number
SE396011B
SE396011B SE7206151A SE615172A SE396011B SE 396011 B SE396011 B SE 396011B SE 7206151 A SE7206151 A SE 7206151A SE 615172 A SE615172 A SE 615172A SE 396011 B SE396011 B SE 396011B
Authority
SE
Sweden
Prior art keywords
carboxychromone
yloxy
propan
bis
procedure
Prior art date
Application number
SE7206151A
Other languages
English (en)
Swedish (sv)
Inventor
N A Stevenson
G Wardell
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26250625&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE396011(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of SE396011B publication Critical patent/SE396011B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Otolaryngology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SE7206151A 1971-05-12 1972-05-09 Forfarande for framstellning av en i huvudsak klar, steril vattenlosning av 1,3-bis(2-karboxikromon-5-yloxi)-propan-2-ol eller ett farmaceutiskt godtagbart salt derav SE396011B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1452971 1971-05-12
GB5716971A GB1399834A (en) 1971-05-12 1971-12-09 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
SE396011B true SE396011B (sv) 1977-09-05

Family

ID=26250625

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7206151A SE396011B (sv) 1971-05-12 1972-05-09 Forfarande for framstellning av en i huvudsak klar, steril vattenlosning av 1,3-bis(2-karboxikromon-5-yloxi)-propan-2-ol eller ett farmaceutiskt godtagbart salt derav

Country Status (15)

Country Link
JP (1) JPS5425082B1 (xx)
AU (1) AU465305B2 (xx)
BE (1) BE782981A (xx)
CA (1) CA1000201A (xx)
CY (1) CY955A (xx)
DE (2) DE2223237C2 (xx)
DK (1) DK131324B (xx)
FR (1) FR2139872B1 (xx)
GB (1) GB1399834A (xx)
HK (1) HK69276A (xx)
IE (1) IE36337B1 (xx)
IL (1) IL39286A (xx)
MY (1) MY7700080A (xx)
NL (1) NL177386B (xx)
SE (1) SE396011B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2230358A2 (en) * 1973-05-25 1974-12-20 Fisons Ltd Cromoglycate contg. solns. - contg. a second therapeutically active cpd. e.g. an antihistamine
DE2634908A1 (de) * 1974-11-09 1977-04-14 Fisons Ltd Mittel zur behandlung chronischer haut- oder augenerkrankungen
DE3700379A1 (de) * 1987-01-08 1988-07-21 Mann Gerhard Chem Pharm Fab Konservierte augentropfen mit einem gehalt an cromoglicinsaeure
DE68915203T2 (de) * 1988-03-22 1994-09-22 Fisons Plc Pharmazeutische Mischungen.
FR2649890A1 (fr) * 1988-03-22 1991-01-25 Fisons Plc Compositions pharmaceutiques
GB8819490D0 (en) * 1988-08-16 1988-09-21 Fisons Plc Pharmaceutical devices
AT410894B (de) * 1988-03-22 2003-08-25 Fisons Plc Verwendung einer wässerigen lösung von natriumcromoglycat und chlorbutol
WO1997024142A1 (fr) * 1995-12-27 1997-07-10 Showa Yakuhin Kako Co., Ltd. Composition aqueuse contenant de l'acide cromoglycique
DE19614823A1 (de) * 1996-04-15 1997-10-16 Mann Gerhard Chem Pharm Fab Ophthalmische Zusammensetzung mit verlängerter Verweilzeit am Auge
EP0938896A1 (en) * 1998-01-15 1999-09-01 Novartis AG Autoclavable pharmaceutical compositions containing a chelating agent
JP5785353B2 (ja) * 2004-02-27 2015-09-30 大正製薬株式会社 眼科用剤
JP5992293B2 (ja) * 2012-10-31 2016-09-14 大正製薬株式会社 眼科用剤
PL426472A1 (pl) * 2018-07-27 2020-02-10 Kalbarczyk Grzegorz Arkona Laboratorium Farmakologii Stomatologicznej Zastosowanie medyczne bromku domifenu oraz kompozycja do leczenia stanów zapalnych w obrębie jamy ustnej

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1144905A (en) * 1965-03-25 1969-03-12 Fisons Pharmaceuticals Ltd Substituted bis-(2-carboxy-chromonyl-oxy) derivatives and preparation and pharmaceutical compositions thereof
GB1190193A (en) * 1966-07-05 1970-04-29 Fisons Pharmaceuticals Ltd Bis-(2-Carboxy-Chromonyl-Oxy) Derivatives, their preparation, and Pharmaceutical Compositions thereof

Also Published As

Publication number Publication date
MY7700080A (en) 1977-12-31
GB1399834A (en) 1975-07-02
DE2223237A1 (de) 1972-12-14
IE36337L (en) 1972-11-12
HK69276A (en) 1976-11-12
IL39286A (en) 1975-02-10
FR2139872B1 (xx) 1975-10-31
DK131324B (da) 1975-06-30
DK131324C (xx) 1975-11-24
IE36337B1 (en) 1976-10-13
CY955A (en) 1978-12-22
DE2223237C2 (de) 1985-01-17
AU4208072A (en) 1973-11-15
JPS5425082B1 (xx) 1979-08-25
NL7206251A (xx) 1972-11-14
NL177386B (nl) 1985-04-16
AU465305B2 (en) 1975-09-25
CA1000201A (en) 1976-11-23
FR2139872A1 (xx) 1973-01-12
BE782981A (fr) 1972-11-03
IL39286A0 (en) 1972-06-28
DE2266025A1 (xx) 1985-03-07

Similar Documents

Publication Publication Date Title
SE402709B (sv) Forfarande for framstellning av ett farmaceutiskt preparat for behandling av hyperkolesterolemi, innehallande p-klorfenoxiisosmorsyra eller vissa estrar eller salter derav
AT327390B (de) Verfahren zur herstellung von festen, denwirkstoff langsam abgebenden pharmazeutischen zubereitungen
DK149895C (da) Fremgangsmaade til fremstilling af alfa-aminoacylprolyl-ng-carboxy-argininaldehydderivater eller farmaceutisk acceptable syreadditionssalte deraf
SE396011B (sv) Forfarande for framstellning av en i huvudsak klar, steril vattenlosning av 1,3-bis(2-karboxikromon-5-yloxi)-propan-2-ol eller ett farmaceutiskt godtagbart salt derav
SE405121B (sv) Forfarande for framstellning av 2-(heteroaryl-metyl)-5-9beta-dialkyl-6,7-bensomorfaner eller deras syraadditionssalter
OA04433A (fr) Procédé de préparation d'éthers diphényliques substitués.
DK125021B (da) Analogifremgangsmåde til fremstilling af 1,2,3,4-tetrahydro-4-phenyl-isoquinolinderivater eller syreadditionssalte deraf eller de tilsvarende optisk aktive forbindelser.
SE419033B (sv) Forfarande for framstellning av ett veterinermedicinskt, antibakteriellt preparat, innehallande bl a n'-(4,5-dimetyl-3-isoxazolyl)-sulfanilamid
DK133899B (da) Analogifremgangsmåde til fremstilling af benzofuranderivater eller farmaceutisk acceptable syreadditionssalte deraf.
SE402009B (sv) Forfarande for framstellning av 9-desoxi-prosta-5,9,(10),13-triensyraderivat
SE422214B (sv) Forfarande for framstellning av antibiotikum a 2041-derivat eller fysiologiskt godtagbart katjoniskt salt derav
DK136722B (da) Analogifremgangsmåde til fremstilling af oxazolidinon-(2)-derivater eller syreadditionssalte heraf.
DK130476B (da) Fremgangsmåde til fremstilling af antibiotikum A 477 eller syreadditionssalte deraf.
DK128779B (da) Analogifremgangsmåde til fremstilling af 2-arylamino-imidazolin-(2)'er eller syreadditionssalte deraf.
SE431216B (sv) Forfarande for framstellning av 1n-(alfa-hydroxi-omega-amino-alkanoyl)-6 721n-metyl-3 721, 4 721-dideoxikanamycin b eller farmaceutiskt godtagbara syraadditionssalter derav
SE396074B (sv) Sett att framstella vissa angivna alkanolaminderivat eller fysiologiskt fordragbara syraadditionssalter derav
DK135574B (da) Fremgangsmåde til fremstilling af benzylaminderivater eller fysiologisk anvendelige syreadditionssalte heraf.
NO144488C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 8,12-diisoprostansyre-derivater
SE425250B (sv) Forfarande for framstellning av vermherdande fenolformaldehydhartser.
SE7700792L (sv) Forfarande for framstellning av n,n'-diklor-isoftalsyraamid
SE403616B (sv) Analogiforfarande for framstellning av dibensoxirenazepinderivat eller farmaceutiskt godtagbara salter derav
AR204615A1 (es) Procedimiento para la preparacion de derivados de 1,3-bis-(hidantoinil-3')-propan-2-ol
DK134436C (da) Analogifremgangsmade til fremstilling af s(iv)-benzo-1,2,4-thiadiaziner eller syreadditionssalte deraf
SE403773B (sv) Forfarande for framstellning av vissa alfa-aminoalkyl-4-hydroxi-3(alkylsulfonylmetyl) bensylalkoholer eller farmaceutiskt acceptabla syraadditionssalter derav
DK139943B (da) Fremgangsmåde til fremstilling af triazolo(4,3a)(1,4)benzodiazepin-5N-oxydderivater eller syreadditionssalte deraf.